[1] |
LI Shan, LIU Yixin, REN Feifei, LI Xiangchen, ZHANG Zhiqing.
Research progress of natural plant active ingredients in reversing tumor multidrug resistance by down-regulating P-gp
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 331-340.
|
[2] |
MENG Qiang, LIU Kexin.
Research status and prospect of transporter-mediated drug-drug interactions
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 876-888.
|
[3] |
LI Xu, Dai Yi, HUANG Jiafeng, WEN Chunjie, ZOU Zhen, Wu Lanxiang, WANG Guo, ZHOU Honghao.
Curcumin increases MDR1 expression in breast cancer MCF-7 and MCF-7/DOX cells through regulating histone acetylation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(5): 512-517.
|
[4] |
WANG Zi-yuan, CHENG Zhuo-an, YIN Pei-hao.
Research advance in resveratrol's inhibition action on multidrug resistance
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(6): 717-720.
|
[5] |
LI Jun, JIANG Kui, ZHANG Xue-mei.
Adervances in the research of multidrug resistance-associated protein 1 and its relationship with tumor
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(3): 351-355.
|
[6] |
WANG Pei-pei, XU Du-juan, HUANG Can, XU Wen-ke, LUAN Jia-jie.
Reversal of human hepatic cancer multidrug resistance is induced by AstragalosideⅡ in BEL-7402/FU cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(2): 139-144.
|
[7] |
LUO Dan, ZHANG Jing-wei, ZHOU Fang, WU Xiao-lan, WANG Guang-ji.
Research progress on the PK evaluation of anti-cancer nano-preparation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(2): 205-211.
|
[8] |
ZHAO Qi-jin, ZHA Wei-bin, ZHOU Fang, WU Xiao-lan, CAO Bei, ZHANG Jing-wei, WANG Guang-ji.
The transcriptional regulation of drug enzymes and transporters mediated by Pregnane X receptor and its significant role in multidrug resistance
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(8): 931-939.
|
[9] |
CAI Ke, ZHOU Rui, SHI Bai-ling.
Effect of Oct-4 on chemosensitivity of cisplatin against gastric cancer cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(3): 251-255.
|
[10] |
WEN Xiao-zhou, ZHOU Fang, WU Xiao-lan, WANG Guang-ji.
Research advance on P-glycoprotein inhibitors and the structure-activity relationship
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(7): 814-820.
|
[11] |
DING Yuan-yuan, YANG Fan, LIU Jing, XU Qian, ZHANG Mei, XU Jing-feng.
Effects of the multidrug resistance 1 gene haplotype on resistance of valproic acid in Chinese Han Epilepsy patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(11): 1267-1272.
|
[12] |
FAN Xiu-zhen, GUO Xin, WANG Hua-jie, CHENG Ze-neng.
Effects of MDR1 gene C3435T polymorphism on the steady-state plasma concentration and hypotensive activity of telmisartan
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(6): 670-676.
|
[13] |
ZHANG Qing-hao, MENG Qiang, LIU Qi, WANG Chang-yuan, MEI Lin, SUN Hui-jun, LIU Kexin.
Construction of determination of cefditoren and the investigation of mechanism of biliary excretion
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(11): 1269-1274.
|
[14] |
HE Hui, CHEN Xi-jing, WANG Guang-ji.
The interaction of Trans -resveratrol and its glucoside Trans peceid with drug transporters
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(4): 366-372.
|
[15] |
LI Nai-jing, LI Yan, PAN Zuo-dong, HE Ping, LI Sheng-qi.
Determination of the AmpC and ESBL produced in the biofilm of klebsiella pneumoniae
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(4): 384-387.
|